79085755

Information

• Trademark
• 79085755

• Source

• Serial Number

  79085755

• Registration Number

  3972716

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 41 - Education
  • 44 - Medical services

• Filing Date

  June 26, 2010
  14 years ago

• Registration Date

  June 07, 2011
  13 years ago

• Transaction Date

  August 03, 2024
  8 months ago

• Status Date

  January 12, 2018
  7 years ago

• Published for Opposition Date

  March 22, 2011
  14 years ago

• Location Date

  June 07, 2011
  13 years ago

• Status Code

  709

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ROACH, APRIL K

• Attorney Docket Number

  5094/82317

  Attorney Name

  Norman H. Zivin

  Law Office Assigned Location Code

  M60

• Owners

  • BIONORICA SE

Case File Statements

• GS0411: Educational services, namely, providing classes and workshops in the field of health, health consciousness and health queries to medical practitioners, health specialists and/or patients, providing of training in particular providing information about education in the field of health, health consciousness and health queries for medical practitioners, health specialists and patients, also via the Internet
• DM0000: The mark consists of a green leaf inside a solid blue circle.
• GS0051: Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flashes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; pharmaceutical preparations for sensory organs, namely, for use in ophthalmology, otolaryngology and dermatology; pharmaceutical preparations for regulation and strengthening of the immune system, pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for health purposes; medicated sanitary preparations for the treatment, cleaning and protection of the skin; dietary supplements in the form of tablets, drops, capsules, extract preparations, balms or in liquid form, containing plant extracts; dietetic substances adapted for medical use, namely, dietetic foods, dietetic beverages, dietetic sugar, dietetic food supplements; medical and surgical plasters; plant extracts for pharmaceutical purposes and plant extracts used as dietetic substances adapted for medical use; nutritional additives for medical purposes, namely, dietary and nutritional supplements for human consumption; medicinal oils; vitamin and mineral supplements; food and food supplements, namely, herbal teas for medicinal purposes and medicinal teas; medicinal herbs; materials for dressings, namely, gauze and bandages; all purpose disinfectants
• CC0000: The color(s) blue and green is/are claimed as a feature of the mark.
• GS0441: Medical services; hygienic and beauty care for human beings; medical consultancy, consultancy in the fields of pharmaceutical advice and health, also via the Internet

Case File Event Statements

• 10/4/2010 - 14 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 9/2/2010 - 14 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 9/3/2010 - 14 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/7/2010 - 14 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 10/4/2010 - 14 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/5/2010 - 14 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 10/5/2010 - 14 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 10/5/2010 - 14 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 11/1/2010 - 14 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 11/19/2010 - 14 years ago

  10 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 1/11/2011 - 14 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/11/2011 - 14 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/11/2011 - 14 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/18/2011 - 14 years ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/18/2011 - 14 years ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/18/2011 - 14 years ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/18/2011 - 14 years ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/18/2011 - 14 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/11/2011 - 14 years ago

  19 - ASSIGNED TO LIE Type: ALIE

• 2/17/2011 - 14 years ago

  20 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 3/3/2011 - 14 years ago

  21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 3/3/2011 - 14 years ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/22/2011 - 14 years ago

  23 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/22/2011 - 14 years ago

  24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/7/2011 - 13 years ago

  25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 9/7/2011 - 13 years ago

  26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/1/2011 - 13 years ago

  27 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/1/2011 - 13 years ago

  28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 4/22/2012 - 12 years ago

  29 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 6/6/2012 - 12 years ago

  30 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 9/12/2018 - 6 years ago

  34 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 2/26/2013 - 12 years ago

  31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 6/12/2014 - 10 years ago

  32 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 1/12/2018 - 7 years ago

  33 - CANCELLED SECTION 71 Type: C71T

• 9/17/2018 - 6 years ago

  35 - GENERIC MADRID TRANSACTION CREATED Type: XXCR

• 9/17/2018 - 6 years ago

  36 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS

• 9/28/2018 - 6 years ago

  37 - REFUSAL PROCESSED BY IB Type: RFNT

• 10/19/2018 - 6 years ago

  38 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 12/4/2018 - 6 years ago

  39 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 12/6/2019 - 5 years ago

  40 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 7/17/2020 - 4 years ago

  41 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL

• 2/22/2023 - 2 years ago

  42 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 4/22/2023 - a year ago

  43 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 5/8/2024 - 11 months ago

  45 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 9/11/2023 - a year ago

  44 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 8/2/2024 - 8 months ago

  46 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP